Winston Wong, PharmD, is the President of the W-Squared Group. The W-Squared Group is committed to assist healthcare innovators develop their value statement and launching their technology in the government and commercial marketplace. Current areas of focus for the W-Squared Group are in tissue and circulating tumor cell genomic profiling in Oncology and hereditary risk as well as the use of biomarkers in other disease states, gene therapy, medical and pharmacy benefit management for self-funded employers, medical/pharmacy outcomes research analytics for payers, employers, and pharmaceutical companies, and the development of clinical pathway in oncology, immunology, urology, and chronic diseases with specialty pharmacy and provider organizations. Disease state focuses include oncology, immunologic disorders, retinal disorders, and the umbrella of dementia disorders. The W-Squared Group works to evaluate marketing strategies for new product launches, providing the perspective of a managed care organization and their potential reaction to the developed strategy as well as market access training.

Dr. Wong was named as one of the Top 100 Healthcare Leaders in 2018 in June 2019, one of the Top 100 Healthcare Visionaries in 2020 in January 2021 by the International Forum on Advancement in Healthcare, and the Outstanding Leadership Award at the Health 2.0 Conference in December 2022 and July 2023.